![]() |
Lens Technology Co., Ltd. (300433.SZ) Évaluation DCF
CN | Technology | Hardware, Equipment & Parts | SHZ
|

- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Lens Technology Co., Ltd. (300433.SZ) Bundle
Que vous soyez un investisseur ou un analyste, cette calculatrice DCF (300433SZ) est votre ressource incontournable pour une évaluation précise. Préchargé avec des données réelles de Lens Technology Co., Ltd., vous pouvez ajuster vos prévisions et observer les effets en temps réel.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 30,257.8 | 36,939.1 | 45,268.1 | 46,698.5 | 54,490.7 | 63,274.0 | 73,473.1 | 85,316.1 | 99,068.1 | 115,036.7 |
Revenue Growth, % | 0 | 22.08 | 22.55 | 3.16 | 16.69 | 16.12 | 16.12 | 16.12 | 16.12 | 16.12 |
EBITDA | 6,300.3 | 9,228.0 | 6,663.5 | 8,171.6 | 8,760.0 | 11,908.0 | 13,827.4 | 16,056.3 | 18,644.4 | 21,649.6 |
EBITDA, % | 20.82 | 24.98 | 14.72 | 17.5 | 16.08 | 18.82 | 18.82 | 18.82 | 18.82 | 18.82 |
Depreciation | 2,709.5 | 3,011.6 | 4,286.8 | 4,640.0 | 4,937.6 | 5,767.4 | 6,697.0 | 7,776.5 | 9,030.0 | 10,485.6 |
Depreciation, % | 8.95 | 8.15 | 9.47 | 9.94 | 9.06 | 9.11 | 9.11 | 9.11 | 9.11 | 9.11 |
EBIT | 3,590.8 | 6,216.5 | 2,376.6 | 3,531.6 | 3,822.4 | 6,140.6 | 7,130.4 | 8,279.7 | 9,614.3 | 11,164.1 |
EBIT, % | 11.87 | 16.83 | 5.25 | 7.56 | 7.01 | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 |
Total Cash | 5,666.2 | 19,275.3 | 11,723.6 | 12,041.2 | 10,868.7 | 18,037.7 | 20,945.2 | 24,321.4 | 28,241.7 | 32,793.9 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 6,837.8 | 8,244.3 | 9,817.6 | 9,026.2 | 9,420.7 | 13,062.5 | 15,168.1 | 17,613.0 | 20,452.0 | 23,748.7 |
Account Receivables, % | 22.6 | 22.32 | 21.69 | 19.33 | 17.29 | 20.64 | 20.64 | 20.64 | 20.64 | 20.64 |
Inventories | 3,212.3 | 6,778.7 | 6,137.3 | 6,685.0 | 6,682.7 | 8,745.0 | 10,154.6 | 11,791.4 | 13,692.0 | 15,899.0 |
Inventories, % | 10.62 | 18.35 | 13.56 | 14.32 | 12.26 | 13.82 | 13.82 | 13.82 | 13.82 | 13.82 |
Accounts Payable | 8,114.9 | 9,852.9 | 10,194.3 | 10,129.8 | 11,132.1 | 14,949.6 | 17,359.3 | 20,157.4 | 23,406.5 | 27,179.4 |
Accounts Payable, % | 26.82 | 26.67 | 22.52 | 21.69 | 20.43 | 23.63 | 23.63 | 23.63 | 23.63 | 23.63 |
Capital Expenditure | -4,520.8 | -5,920.1 | -6,843.4 | -6,852.4 | -5,443.4 | -8,953.1 | -10,396.2 | -12,072.0 | -14,017.8 | -16,277.3 |
Capital Expenditure, % | -14.94 | -16.03 | -15.12 | -14.67 | -9.99 | -14.15 | -14.15 | -14.15 | -14.15 | -14.15 |
Tax Rate, % | 7.15 | 7.15 | 7.15 | 7.15 | 7.15 | 7.15 | 7.15 | 7.15 | 7.15 | 7.15 |
EBITAT | 3,122.1 | 5,329.9 | 2,279.5 | 2,965.9 | 3,549.3 | 5,470.5 | 6,352.3 | 7,376.2 | 8,565.1 | 9,945.7 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -624.4 | -813.6 | -867.6 | 932.9 | 3,653.5 | 398.1 | 1,547.7 | 1,797.1 | 2,086.8 | 2,423.2 |
WACC, % | 10.96 | 10.96 | 11 | 10.95 | 10.99 | 10.97 | 10.97 | 10.97 | 10.97 | 10.97 |
PV UFCF | ||||||||||
SUM PV UFCF | 5,746.7 | |||||||||
Long Term Growth Rate, % | 3.50 | |||||||||
Free cash flow (T + 1) | 2,508 | |||||||||
Terminal Value | 33,572 | |||||||||
Present Terminal Value | 19,950 | |||||||||
Enterprise Value | 25,696 | |||||||||
Net Debt | 5,866 | |||||||||
Equity Value | 19,830 | |||||||||
Diluted Shares Outstanding, MM | 4,953 | |||||||||
Equity Value Per Share | 4.00 |
What You Will Receive
- Comprehensive LENS Financials: Contains historical and projected data for precise valuation.
- Customizable Inputs: Adjust parameters such as WACC, tax rates, revenue growth, and capital expenditures.
- Dynamic Calculations: Intrinsic value and NPV are calculated automatically.
- Scenario Analysis: Evaluate various scenarios to assess Lens Technology’s future performance.
- User-Friendly Design: Designed for professionals while remaining accessible to newcomers.
Key Features
- Comprehensive Lens Technology Data: Pre-loaded with Lens Technology Co., Ltd.'s historical financials and projected growth metrics.
- Fully Customizable Inputs: Tailor revenue growth rates, profit margins, WACC, tax rates, and capital expenditures to your needs.
- Dynamic Valuation Model: Automatically refreshes Net Present Value (NPV) and intrinsic value based on user-defined parameters.
- Scenario Testing: Generate various forecasting scenarios to evaluate different valuation results.
- User-Friendly Interface: Intuitive design suitable for both professionals and novices in financial analysis.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-filled data for Lens Technology Co., Ltd. (300433SZ), including historical and projected figures.
- Step 3: Modify key assumptions (highlighted in yellow) based on your evaluation.
- Step 4: Observe automatic recalculations of Lens Technology’s intrinsic value.
- Step 5: Utilize the results for investment analysis or reporting purposes.
Why Choose Lens Technology Co., Ltd. (300433SZ)?
- Time-Efficient: Instantly access advanced calculations without starting from scratch.
- Enhanced Precision: Dependable data and methodologies minimize valuation errors.
- Completely Customizable: Adjust the model to align with your specific assumptions and forecasts.
- User-Friendly: Intuitive charts and outputs facilitate straightforward analysis of results.
- Endorsed by Professionals: Crafted for industry experts who prioritize accuracy and functionality.
Who Should Use This Product?
- Investors: Evaluate Lens Technology Co., Ltd.'s (300433SZ) valuation before making stock transactions.
- CFOs and Financial Analysts: Optimize valuation workflows and assess financial projections for Lens Technology Co., Ltd. (300433SZ).
- Startup Founders: Gain insights into how leading companies like Lens Technology Co., Ltd. (300433SZ) determine their market value.
- Consultants: Create comprehensive valuation reports tailored for clients involving Lens Technology Co., Ltd. (300433SZ).
- Students and Educators: Utilize real-world data from Lens Technology Co., Ltd. (300433SZ) to practice and instruct in valuation methodologies.
Contents of the Template
- Preloaded LENS Data: Historical and projected financial figures, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets designed for calculating intrinsic value and the Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for modifying revenue growth, tax rates, and discount rates.
- Financial Statements: Extensive annual and quarterly financials for detailed analysis.
- Key Ratios: Metrics on profitability, leverage, and efficiency for performance evaluation.
- Dashboard and Charts: Visual representations of valuation outcomes and underlying assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.